Evidence map›Paper›PMID 32583356›Full record

SynthesisEuropean journal of clinical pharmacology2020

Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.

Abolfazl Akbari, Gholam Reza Mobini, Shahram Agah, Mojgan Morvaridzadeh, Amirhossein Omidi, Eric Potter, Siavash Fazelian, Seyed Hossein Ardehali, Elnaz Daneshzad, Sadegh Dehghani

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Abolfazl AkbariColorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
Gholam Reza MobiniCellular & Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences (SkUMS), Shahrekord, Iran.
Shahram AgahColorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mojgan MorvaridzadehDepartment of Nutritional Science, School of Nutritional Science and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Amirhossein OmidiDepartment of Nutritional Science, School of Nutritional Science and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Eric PotterBaylor Scott & White Research Institute, Dallas, Texas, USA.
Siavash FazelianClinical Research Development Unit, Ayatollah Kashani Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Seyed Hossein ArdehaliDepartment of Anesthesiology and Critical Care, Shohadaye Tajrish Hospital, Tehran, Iran.
Elnaz DaneshzadDepartment of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
Sadegh DehghaniRadiation Sciences Department, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran. dehghan907@yahoo.com.ORCID http://orcid.org/0000-0001-5713-7815
Iran University of Medical Sciences · IRKermanshah University of Medical Sciences · IRShahrekord University of Medical Sciences · IRBaylor Medical Center at Garland · USRoozbeh Hospital · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOxidative stress (OS) is associated with several chronic complications and diseases. The use of coenzyme Q10 (CoQ10) as an adjuvant treatment with routine clinical therapy against metabolic diseases has shown to be beneficial. However, the impact of CoQ10 as a preventive agent against OS has not been systematically investigated.

methodsA systematic literature search was performed using the PubMed, SCOPUS, EMBASE, and Cochrane Library databases to identify randomized clinical trials evaluating the efficacy of CoQ10 supplementation on OS parameters. Standard mean differences and 95% confidence intervals were calculated for net changes in OS parameters using a random-effects model.

resultsSeventeen randomized clinical trials met the eligibility criteria to be included in the meta-analysis. Overall, CoQ10 supplementation was associated with a statistically significant decrease in malondialdehyde (MDA) (SMD - 0.94; 95% CI - 1.46, - 0.41; I

conclusionCoQ10 supplementation, in the tested range of doses, was shown to reduce MDA concentrations, and increase TAC and antioxidant defense system enzymes. However, there were no significant effects of CoQ10 on NO, GSH concentrations, or CAT activity.

Indexed as

Oxidative StressCatalaseDietary SupplementsGlutathione PeroxidaseHumansMalondialdehydeRandomized Controlled Trials as TopicSuperoxide DismutaseUbiquinoneCatalasecoenzyme Q10Glutathione PeroxidaseMalondialdehydeSuperoxide DismutaseUbiquinoneCoenzyme Q10Glutathione peroxidaseMalondialdehydeOxidative stress

Identifiers

PMID32583356
OpenAlexW3037741504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.